3.74
-0.06 (-1.58%)
前收盘价格 | 3.80 |
收盘价格 | 3.85 |
成交量 | 17,902 |
平均成交量 (3个月) | 12,623 |
市值 | 43,280,404 |
价格/销量 (P/S) | 61.68 |
股市价格/股市净资产 (P/B) | 2.37 |
52周波幅 | |
利润日期 | 4 Nov 2024 |
营业利益率 (TTM) | -1,769.48% |
稀释每股收益 (EPS TTM) | -1.53 |
季度收入增长率 (YOY) | -97.60% |
总债务/股东权益 (D/E MRQ) | 16.33% |
流动比率 (MRQ) | 6.27 |
营业现金流 (OCF TTM) | -2.75 M |
杠杆自由现金流 (LFCF TTM) | 2.13 M |
资产报酬率 (ROA TTM) | -33.77% |
股东权益报酬率 (ROE TTM) | -61.55% |
市场趋势
短期 | 中期 | ||
行业 | Biotechnology (US) | 混合的 | 混合的 |
Biotechnology (全球的) | 混合的 | 混合的 | |
股票 | CollPlant Biotechnologies Ltd. | 混合的 | 看涨 |
AIStockmoo 评分
分析师共识 | 4.0 |
内部交易活动 | NA |
价格波动 | 0.5 |
技术平均移动指标 | -1.5 |
技术振荡指标 | -2.5 |
平均 | 0.13 |
CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives key revenue, Canada, Europe and Other, and Israel. |
|
部门 | Healthcare |
行业 | Biotechnology |
投资方式 | Small Value |
内部持股比例 | 10.16% |
机构持股比例 | 12.23% |
所有权
姓名 | 日期 | 持有股份 |
---|---|---|
Benjamin Edwards Inc | 30 Sep 2024 | 23,810 |
52周波幅 | ||
目标价格波幅 | ||
高 | 14.00 (D. Boral Capital, 274.33%) | 购买 |
中 | 12.50 (234.23%) | |
低 | 11.00 (HC Wainwright & Co., 194.12%) | 购买 |
平均值 | 12.50 (234.23%) | |
总计 | 2 购买 | |
平均价格@调整类型 | 4.36 |
公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
---|---|---|---|---|
HC Wainwright & Co. | 29 Nov 2024 | 11.00 (194.12%) | 购买 | 4.48 |
D. Boral Capital | 27 Nov 2024 | 14.00 (274.33%) | 购买 | 4.25 |
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能(AI)模型生成的,请谨慎解读。
投资组合